Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
Journal: The New England journal of medicine
Published: May 09, 2025
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single-Dose Administration in Healthy Japanese and White Adults.
Journal: Journal of clinical pharmacology
Published: May 10, 2024
Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus.
Journal: Diabetologia
Published: June 08, 2018
Hospital admissions for severe infections in people with chronic kidney disease in relation to renal disease severity and diabetes status.
Journal: Endocrinology, diabetes & metabolism
Published: May 11, 2018
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
Journal: Lancet (London, England)
Published: February 12, 2018
Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates .
Journal: International journal of clinical pharmacology and therapeutics
Published: June 08, 2017
Effect of Anti-IL-13 Treatment on Airway Dimensions in Severe Asthma.
Journal: American journal of respiratory and critical care medicine
Published: July 02, 2016
An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.
Journal: Pulmonary pharmacology & therapeutics
Published: May 14, 2015
Pharmacokinetics of tralokinumab in adolescents with asthma: implications for future dosing.
Journal: British journal of clinical pharmacology
Published: April 14, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026